Identiteta

Crizotinib Amine Impurity

CAS 877397-71-2 · C13H11Cl2FN2O

01Identiteta

Lazychem IDLC-11476
CAS RN877397-71-2
PubChem CID49765905
Molecular formulaC13H11Cl2FN2O
Molecular weight301.1 g/mol
IUPAC name(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine
InChIKeyIEKMAKBQCRKWLS-SSDOTTSWSA-N

02Struktura in stereokemija

2D structurePubChem CID 49765905
Two-dimensional chemical structure of Crizotinib Amine Impurity, CAS 877397-71-2
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count2
Secondary amines0
Tertiary amines0
SMILESC[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC=C2)N
InChINi navedeno

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status v Indiji

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Imena in povezave

API in matično zdravilo

Crizotinib

Nečistote in sorodne spojine

Imena in povezave

  • Crizotinib Impurity 4 / Crizotinib Amine Impurity
  • Crizotinib Amine Impurity
  • Crizotinib Impurity 4
  • 3-[(1R)-1-(2, 6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine
  • 2-Pyridinamine, 3-[(1R)-1-(2, 6-dichloro-3-fluorophenyl)ethoxy]

Nečistote in sorodne spojine

06Viri